Max Horowitz

424 total citations
14 papers, 310 citations indexed

About

Max Horowitz is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Max Horowitz has authored 14 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 9 papers in Surgery and 4 papers in Obstetrics and Gynecology. Recurrent topics in Max Horowitz's work include Ovarian cancer diagnosis and treatment (12 papers), Intraperitoneal and Appendiceal Malignancies (9 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Max Horowitz is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Intraperitoneal and Appendiceal Malignancies (9 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Max Horowitz collaborates with scholars based in United States and Saudi Arabia. Max Horowitz's co-authors include Qing Bai, Jason R. Cannon, Edward A. Burton, Alevtina Zharikov, Amina El Ayadi, Vı́ctor Tapias, Teresa G. Hastings, J. Timothy Greenamyre, Vipul Shah and Peter G. Rose and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Max Horowitz

14 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Horowitz United States 9 105 101 94 84 65 14 310
R. Petrillo Italy 8 26 0.2× 68 0.7× 111 1.2× 99 1.2× 53 0.8× 20 301
Athena L. Chen United States 10 7 0.1× 36 0.4× 68 0.7× 22 0.3× 69 1.1× 20 281
Ameeta Mehta United Kingdom 10 62 0.6× 90 0.9× 29 0.3× 15 0.2× 270 4.2× 11 682
Yoshio Tokuda Japan 9 23 0.2× 28 0.3× 333 3.5× 108 1.3× 52 0.8× 16 454
Joan Young United States 4 14 0.1× 24 0.2× 117 1.2× 41 0.5× 16 0.2× 4 264
N M A Abelin Brazil 9 60 0.6× 73 0.7× 17 0.2× 14 0.2× 99 1.5× 16 302
Daniela Rubino Italy 10 24 0.2× 36 0.4× 8 0.1× 25 0.3× 153 2.4× 28 316
Mary Hanna United States 6 19 0.2× 82 0.8× 12 0.1× 48 0.6× 46 0.7× 10 360
Josephine Morris United States 5 30 0.3× 146 1.4× 50 0.5× 18 0.2× 25 0.4× 7 368
Daniel D. Gruber United States 12 21 0.2× 150 1.5× 6 0.1× 21 0.3× 52 0.8× 43 318

Countries citing papers authored by Max Horowitz

Since Specialization
Citations

This map shows the geographic impact of Max Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Horowitz more than expected).

Fields of papers citing papers by Max Horowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Horowitz. The network helps show where Max Horowitz may publish in the future.

Co-authorship network of co-authors of Max Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Max Horowitz. A scholar is included among the top collaborators of Max Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Horowitz. Max Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2022). Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer. Gynecologic Oncology Reports. 40. 100951–100951. 5 indexed citations
3.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2021). Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gynecologic Oncology. 162(3). 645–651. 11 indexed citations
4.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2021). Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecologic Oncology. 162(2). 368–374. 25 indexed citations
5.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2021). Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry. International Journal of Gynecological Cancer. 31(7). 1021–1030. 6 indexed citations
6.
Chambers, Laura, Meng Yao, Anna Chichura, et al.. (2021). Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecologic Oncology. 161(2). 389–395. 15 indexed citations
7.
8.
Horowitz, Max, et al.. (2020). Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity. Annals of Translational Medicine. 8(14). 905–905. 19 indexed citations
9.
Chambers, Laura, Michelle Kuznicki, Max Horowitz, et al.. (2020). A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology. Gynecologic Oncology. 158(3). 794–802. 25 indexed citations
10.
Kuznicki, Michelle, et al.. (2020). Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature. Journal of Minimally Invasive Gynecology. 28(3). 513–526.e1. 28 indexed citations
11.
12.
Matsuo, Koji, Hiroko Machida, Max Horowitz, et al.. (2017). Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer. American Journal of Obstetrics and Gynecology. 217(5). 580.e1–580.e10. 15 indexed citations
13.
Horowitz, Max, Brian Orr, Paniti Sukumvanich, Joseph L. Kelley, & Sarah E. Taylor. (2017). Rate of ovarian micrometastasis in endometrial cancer: Is ovarian preservation a reasonable option?. Gynecologic Oncology. 145. 38–38. 2 indexed citations
14.
Zharikov, Alevtina, Jason R. Cannon, Vı́ctor Tapias, et al.. (2015). shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model. Journal of Clinical Investigation. 125(7). 2721–2735. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Petrillo Breakdown of academic impact, for papers by Athena L. Chen Breakdown of academic impact, for papers by Ameeta Mehta Breakdown of academic impact, for papers by Yoshio Tokuda Breakdown of academic impact, for papers by Joan Young Breakdown of academic impact, for papers by N M A Abelin Breakdown of academic impact, for papers by Daniela Rubino Breakdown of academic impact, for papers by Mary Hanna Breakdown of academic impact, for papers by Josephine Morris Breakdown of academic impact, for papers by Daniel D. Gruber
Rankless by CCL
2026